Activation of myocardial angiogenesis and upregulation of fibroblast growth factor-2 in transmyocardial-revascularization-treated mice

被引:7
作者
Chiotti, K
Choo, SJ
Martin, SL
Reichert, C
Grass, TM
Duran, CMG
Coffin, JD
机构
[1] Univ Montana, Dept Pharmaceut Sci, Missoula, MT 59812 USA
[2] McLaughlin Res Inst, Great Falls, MT USA
[3] Int Heart Inst, Missoula, MT USA
[4] Benefis Hosp, Dept Pathol, Great Falls, MT USA
关键词
transmyocardial laser revascularization; angiogenesis; mouse; fibroblast growth factor; vascular endothelial cell growth factor; microvascular; myocardium;
D O I
10.1097/00019501-200010000-00004
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective To evaluate the growth factor responses associated with myocardial angiogenesis, Design Mice were treated with transmyocardial revascularization (TMR) and evaluated for angiogenic and growth factor responses. Methods TMR was performed via thoractomy with a 27 g needle. At 2, 5, and 7 days post-treatment, hearts were removed from the TMR treated and control groups, then assayed for angiogenesis, fibroblast growth factor (FGF)-2 expression and vascular endothelial cell growth factor (VEGF) expression, Results TMR caused an angiogenic reaction in the myocardial blood vessels at 7 days post-TMR treatment, Elevated FGF-2 corresponded with increased TMR related angiogenesis. VEGF levels only increased in hearts that were prewounded then TMR treated. Conclusions The data show that TMR stimulates myocardial angiogenesis. The angiogenic reaction is mediated by FGF-2 which increased in most experimental treatment groups, The VEGF response was more specific, requiring prewounding then TMR treatment for a VEGF increase, Coron Artery Dis 11:537-544 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 32 条
[1]
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]
Cardiac sympathetic denervation after transmyocardial laser revascularization [J].
Al-Sheikh, T ;
Allen, KB ;
Straka, SP ;
Heimansohn, DA ;
Fain, RL ;
Hutchins, GD ;
Sawada, SG ;
Zipes, DP ;
Engelstein, ED .
CIRCULATION, 1999, 100 (02) :135-140
[3]
ABNORMAL BONE-GROWTH AND SELECTIVE TRANSLATIONAL REGULATION IN BASIC FIBROBLAST GROWTH-FACTOR (FGF-2) TRANSGENIC MICE [J].
COFFIN, JD ;
FLORKIEWICZ, RZ ;
NEUMANN, J ;
MORTHOPKINS, T ;
DORN, GW ;
LIGHTFOOT, P ;
GERMAN, R ;
HOWLES, PN ;
KIER, A ;
OTOOLE, BA ;
SASSE, J ;
GONZALEZ, AM ;
BAIRD, A ;
DOETSCHMAN, T .
MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (12) :1861-1873
[4]
ANGIOBLAST DIFFERENTIATION AND MORPHOGENESIS OF THE VASCULAR ENDOTHELIUM IN THE MOUSE EMBRYO [J].
COFFIN, JD ;
HARRISON, J ;
SCHWARTZ, S ;
HEIMARK, R .
DEVELOPMENTAL BIOLOGY, 1991, 148 (01) :51-62
[5]
Corda S, 1997, CIRC RES, V81, P679
[6]
DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974
[7]
Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[8]
VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) AND VEGF RECEPTOR-2 (FLK-1) ARE EXPRESSED DURING VASCULOGENESIS AND VASCULAR DIFFERENTIATION IN THE QUAIL EMBRYO [J].
FLAMME, I ;
BREIER, G ;
RISAU, W .
DEVELOPMENTAL BIOLOGY, 1995, 169 (02) :699-712
[9]
One-month histologic response of transmyocardial laser channels with molecular intervention [J].
Fleischer, KJ ;
GoldschmidtClermont, PJ ;
Fonger, JD ;
Hutchins, GM ;
Hruban, RH ;
Baumgartner, WA .
ANNALS OF THORACIC SURGERY, 1996, 62 (04) :1051-1058
[10]
FULGHAM DL, 1998, ENDOTHELIUM, V6, P185